Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 Substitution in Chronic Lymphoid Leukemia
NCT01518959Phase 3Terminated
- Sponsor
- Semmelweis University
- Start
- Jan 2012
- Primary completion
- Jan 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of vitamin d in chronic lymphocytic leukemia (CLL) (2 arms), sponsored by Semmelweis University. Primary endpoint: Overall Survival up to 5 years. Started Jan 2012; status: terminated.
02
Drugs
vitamin d
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT01518959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01518959.